Announcement

Collapse
No announcement yet.

Virol Sin. Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Virol Sin. Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women


    Virol Sin. 2020 Apr 20. doi: 10.1007/s12250-020-00227-0. [Epub ahead of print]
    Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women.


    Wu C1, Yang W2, Wu X1, Zhang T1, Zhao Y1, Ren W3, Xia J4.

    Author information




    Abstract

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic has become a major challenge to public health in China and other countries, considering its pathogenicity across all age groups. Pregnancy is a unique physiological condition, and is characterized by altered immunity and elevated hormone levels to actively tolerate the semi-allogeneic fetus, which undergoes a sudden and substantial fluctuation during the immediate postpartum period. Changes in clinical features, laboratory characteristics, and imaging features of pregnant women during the pre-partum and post-partum periods require further elucidation. Here, we retrospectively analyzed the clinical features, laboratory characteristics, and imaging features of eight pregnant cases of SARS-CoV-2 infection during the pre-partum and post-partum periods. Our results showed that four of the eight pregnant women were asymptomatic before delivery but became symptomatic post-partum. Correspondingly, white blood cell (WBC) counts increased and lymphocyte (LYMPH) counts decreased. C-reactive protein (CRP) levels in the serum also increased to a higher level than those in general pregnancy. Therefore, it is imperative to closely monitor laboratory parameters including the WBC count, LYMPH count, and CRP, along with other imaging features in chest CT scans, to promptly prevent, diagnose, and treat a SARS-CoV-2 infection during pregnancy.



    KEYWORDS:

    Clinical manifestation; Immunity; Laboratory characteristics; Pregnant women; SARS-CoV-2


    PMID:32314274DOI:10.1007/s12250-020-00227-0

Working...
X